Suso Platero
Life Sciences Discovery Fund(US)Newtown Hospital(GB)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors(2015)380 cited
- → Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection(2007)343 cited
- → Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor(2017)336 cited
- → Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients(2019)227 cited
- → The Case for a Pre-Cancer Genome Atlas (PCGA)(2016)101 cited
- → Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions(2019)96 cited
- → A Phase I First-in-Human Pharmacokinetic and Pharmacodynamic Study of Serdemetan in Patients with Advanced Solid Tumors(2011)63 cited
- → Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib(2017)63 cited
- → Immuno-oncology trends: preclinical models, biomarkers, and clinical development(2022)59 cited
- → Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression(2017)48 cited